By David Ingram NEW YORK (Reuters) - Former drug executive Martin Shkreli, who last year became a lightning rod for outrage over soaring prescription drug prices, may face add ..
LONDON (Reuters) - Global manufacturing growth almost stalled last month as rising price halted a pick-up in new orders, a survey showed on Tuesday. ..
CARACAS/HOUSTON (Reuters) - Venezuelan state oil firm PDVSA has issued at least $310 million in debt to companies including General Electric Co (GE.N) as it negotiates private ..
Pfizer Inc , which last month abandoned its $160 billion (109.90 billion pound) quest for Allergan Inc , reported quarterly results that blew past analyst estimates on sales o ..
The Fed will start selling its bonds this year, which we might as well call 'reverse QE' ..
U.S. pharmaceutical companies dominated an annual global ranking of top 10 large-cap stocks with the best five-year returns, according to an analysis released on Tuesday by Bo ..
Vanguard Group has fixed a software application after a glitch caused some clients to see inflated account balances on their Apple mobile devices, a spokeswoman said on Tuesda ..
Sprint's net loss widened to $554 million, or 14 cents per share, from $224 million, or 6 cents per share, and fell short of the average analyst estimate of a net loss of ..
The United States could see two further interest rate rises this year but uncertainties abound including the impact on the U.S. economy should Britain vote to leave the Europe ..
The bank which warned about a made-in-China "global recession" as one of 2016's key risks is singing a modestly more optimistic tune on the state of the world e ..